Claudio Gasperini Selected Research

Anterograde Amnesia

1/2021

Ozone-induced encephalopathy: A novel iatrogenic entity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudio Gasperini Research Topics

Disease

58	Multiple Sclerosis 11/2022 - 01/2002
18	Relapsing-Remitting Multiple Sclerosis 02/2022 - 11/2003
5	Inflammation (Inflammations) 01/2020 - 06/2003
3	Disease Progression 08/2021 - 01/2020
3	Atrophy 01/2021 - 11/2013
2	Infections 06/2022 - 11/2020
2	Progressive Multifocal Leukoencephalopathy 02/2022 - 11/2015
2	Fatigue 03/2020 - 01/2019
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2017 - 10/2015
2	Autoimmune Diseases (Autoimmune Disease) 10/2015 - 10/2005
1	Dementia (Dementias) 07/2022
1	Parkinsonian Disorders (Parkinsonism) 07/2022
1	Chronic Progressive Multiple Sclerosis 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Demyelinating Diseases (Demyelinating Disease) 08/2021
1	Lymphopenia (Lymphocytopenia) 06/2021
1	Anterograde Amnesia 01/2021
1	Neck Pain (Cervicalgia) 01/2021
1	Psychomotor Agitation (Akathisia) 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Cortical Blindness (Anton Syndrome) 01/2021
1	Vertigo (Positional Vertigo) 01/2021
1	Unconsciousness (Loss of Consciousness) 01/2021
1	Virus Diseases (Viral Diseases) 06/2019
1	Cognitive Dysfunction 01/2019
1	Necrosis 01/2019
1	Neutropenia 09/2018
1	Vascular Diseases (Vascular Disease) 01/2018
1	Ganglion Cysts (Ganglion) 02/2015
1	Hypoxia (Hypoxemia) 07/2014
1	Chronic Disease (Chronic Diseases) 12/2011

Drug/Important Bio-Agent (IBA)

8	Interferon-betaIBA 01/2014 - 01/2002
6	Natalizumab (Tysabri)FDA Link 11/2022 - 01/2012
5	InterferonsIBA 07/2016 - 06/2002
4	Pharmaceutical PreparationsIBA 08/2021 - 06/2003
4	Dimethyl FumarateIBA 06/2021 - 01/2014
4	CytokinesIBA 01/2020 - 03/2014
4	Fingolimod Hydrochloride (FTY720)FDA Link 10/2018 - 01/2012
4	AntibodiesIBA 01/2014 - 06/2003
3	nitazoxanide (NTZ)FDA Link 02/2022 - 11/2015
3	nabiximols (Sativex)IBA 01/2022 - 01/2017
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2014
3	4-Aminopyridine (4 Aminopyridine)FDA Link 01/2021 - 01/2019
3	Glatiramer Acetate (Copaxone)FDA Link 11/2020 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2006
2	VaccinesIBA 01/2022 - 11/2021
2	Dronabinol (THC)FDA LinkGeneric 10/2020 - 01/2020
2	CannabidiolIBA 10/2020 - 01/2020
2	Immunoglobulin G (IgG)IBA 05/2017 - 10/2005
2	Interleukin-17 (Interleukin 17)IBA 08/2015 - 03/2014
2	Lactic Acid (Lactate)FDA LinkGeneric 02/2015 - 07/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2013 - 01/2002
2	Neutralizing AntibodiesIBA 10/2009 - 01/2002
1	Levodopa (L Dopa)FDA LinkGeneric 07/2022
1	CannabinoidsIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	siponimodIBA 01/2022
1	teriflunomideIBA 08/2021
1	Influenza Vaccines (Influenza Vaccine)FDA Link 04/2021
1	ocrelizumabIBA 04/2021
1	OzoneIBA 01/2021
1	LipidsIBA 01/2020
1	lipoxin B4IBA 01/2020
1	lipoxin A4IBA 01/2020
1	EicosanoidsIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 06/2019
1	resiquimodIBA 06/2019
1	InterleukinsIBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	Alemtuzumab (Campath)FDA Link 09/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	AcetylcholinesteraseIBA 01/2018
1	ButyrylcholinesteraseIBA 01/2018
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2018
1	anti-aquaporin 4 autoantibodyIBA 01/2018
1	opicinumabIBA 11/2017
1	Monoclonal AntibodiesIBA 11/2017
1	Purinergic P2X7 ReceptorsIBA 01/2017
1	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2016
1	p38 Mitogen-Activated Protein KinasesIBA 10/2015
1	Retinaldehyde (Retinal)IBA 02/2015
1	Interleukin-8 (Interleukin 8)IBA 03/2014
1	ChemokinesIBA 03/2014
1	Interleukin-6 (Interleukin 6)IBA 03/2014
1	Biological ProductsIBA 01/2014
1	Staphylococcal Protein A (Protein A)IBA 01/2014
1	Neuroprotective AgentsIBA 11/2013
1	laquinimodIBA 11/2013
1	anandamide (arachidonylethanolamide)IBA 05/2013
1	AntigensIBA 01/2013
1	Human Serum Albumin FDA LinkGeneric 01/2012
1	Bovine Serum AlbuminIBA 01/2012
1	Immunologic Factors (Immunomodulators)IBA 01/2012
1	TabletsIBA 09/2010
1	Cladribine FDA LinkGeneric 09/2010
1	Interferon beta-1a FDA Link 07/2010

Therapy/Procedure

17	Therapeutics 10/2022 - 03/2006
5	Injections 01/2022 - 02/2017
1	Ligation 03/2014
1	Parenteral Infusions 12/2011